Recommended videos you might also like
12:14
European experience with Ellipsys
![](https://reachora-public-videos.imgix.net/v/10/e/3/c762d5-766c-4398-9847-12323697aedc/thumbnails/image_1.jpg)
11:39
Arterial venous grafts in the thigh and groin
![](https://reachora-public-videos.imgix.net/v/10/b/5/2f2448-0b0a-41a4-8bff-7d7ba62e5203/thumbnails/image_1.jpg)
13:41
The HeRO and SuperheRO (for the upper and lower limb)
![](https://reachora-public-videos.imgix.net/v/10/e/f/ebff0f-6bff-4f1f-88fc-a34f43fcc64c/thumbnails/image_1.jpg)
06:11
Upper limb arterial venous grafts-options and outcomes
![](https://reachora-public-videos.imgix.net/v/10/3/e/9a0ce7-1440-4891-921a-df66bf101c2c/thumbnails/image_1.jpg)
11:55
Flixene graft in vascular access
![](https://reachora-public-videos.imgix.net/v/10/7/a/f155ce-6e9d-480d-a7d9-09a220a440a0/thumbnails/image_1.jpg)
09:55
European Renal Best Practice vascular access guidelines update
![](https://reachora-public-videos.imgix.net/v/10/a/c/f65535-3cb3-4583-8a38-7829ead9f089/thumbnails/image_1.jpg)
Defining end-stage vascular access (ESVA). Why does ESVA occur? What are the solutions? Epidemiology of vascular access failure
7 views
Uploaded on Aug 30, 2018
Join the conversation
to comment